Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eishi Baba

Showing results (101-110 of 189) with videos related to

Pageof 19
Sort By:
Cancer Science|October 10, 2018
Epidermal growth factor receptor promotes glioma progression by regulating xCT and GluN2B-containing N-methyl-d-aspartate-sensitive glutamate receptor signalingKentaro Suina, Kenji Tsuchihashi, Juntaro Yamasaki, et al.
Cancer Chemotherapy and Pharmacology|February 23, 2015
Amrubicin monotherapy for patients with extrapulmonary neuroendocrine carcinoma after platinum-based chemotherapyKenta Nio, Shuji Arita, Taichi Isobe, et al.
Annals of Surgical Oncology|October 7, 2024
Phase II Trial of Adjuvant S-1 Following Neoadjuvant Chemotherapy and Surgery in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma: The PIECE TrialMotoo Nomura, Toshifumi Yamaguchi, Keisho Chin, et al.
Case Reports in Oncology|March 30, 2022
Spontaneous Regression of Metachronous Intra-Abdominal Desmoid Tumor in a Patient with Familial Adenomatous PolyposisKenji Tsuchihashi, Kyoko Yamaguchi, Ryosuke Taguchi, et al.
BMC Cancer|May 7, 2022
Decision making for anti-VEGF inhibitor continuation: dip stick? or urine protein/creatinine ratio? (VERSiON UP study)Michio Nakamura, Taro Funakoshi, Shigeki Kataoka, et al.
Cancer Science|November 17, 2010
Phase I/II study of a 3-week cycle of irinotecan and S-1 in patients with advanced colorectal cancerHitoshi Kusaba, Taito Esaki, Kitaro Futami, et al.
Cancer Chemotherapy and Pharmacology|July 26, 2018
The risk factors for oxaliplatin-induced peripheral sensory neuropathy and thrombocytopenia in advanced gastric cancerKyoko Yamaguchi, Hitoshi Kusaba, Akitaka Makiyama, et al.
Cancer Science|August 2, 2018
Activation of central/effector memory T cells and T-helper 1 polarization in malignant melanoma patients treated with anti-programmed death-1 antibodyKyoko Yamaguchi, Koji Mishima, Hirofumi Ohmura, et al.
Case Reports in Oncology|September 10, 2014
Successful chemoradiotherapy for undifferentiated malignant neoplasm arising from the left pulmonary arteryHozumi Kumagai, Kenta Nio, Yuta Okumura, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|April 12, 2025
Elucidation of the mechanism of carcinogenic transformation of human gastric epithelial cells in atrophic gastritisTomoyasu Yoshihiro, Kyoko Yamaguchi, Hiroshi Ariyama, et al.
Pageof 19

Showing results (101-110 of 189) with videos related to

Sort By:
Pageof 19
Cancer Science|October 10, 2018
Epidermal growth factor receptor promotes glioma progression by regulating xCT and GluN2B-containing N-methyl-d-aspartate-sensitive glutamate receptor signalingKentaro Suina, Kenji Tsuchihashi, Juntaro Yamasaki, et al.
Cancer Chemotherapy and Pharmacology|February 23, 2015
Amrubicin monotherapy for patients with extrapulmonary neuroendocrine carcinoma after platinum-based chemotherapyKenta Nio, Shuji Arita, Taichi Isobe, et al.
Annals of Surgical Oncology|October 7, 2024
Phase II Trial of Adjuvant S-1 Following Neoadjuvant Chemotherapy and Surgery in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma: The PIECE TrialMotoo Nomura, Toshifumi Yamaguchi, Keisho Chin, et al.
Case Reports in Oncology|March 30, 2022
Spontaneous Regression of Metachronous Intra-Abdominal Desmoid Tumor in a Patient with Familial Adenomatous PolyposisKenji Tsuchihashi, Kyoko Yamaguchi, Ryosuke Taguchi, et al.
BMC Cancer|May 7, 2022
Decision making for anti-VEGF inhibitor continuation: dip stick? or urine protein/creatinine ratio? (VERSiON UP study)Michio Nakamura, Taro Funakoshi, Shigeki Kataoka, et al.
Cancer Science|November 17, 2010
Phase I/II study of a 3-week cycle of irinotecan and S-1 in patients with advanced colorectal cancerHitoshi Kusaba, Taito Esaki, Kitaro Futami, et al.
Cancer Chemotherapy and Pharmacology|July 26, 2018
The risk factors for oxaliplatin-induced peripheral sensory neuropathy and thrombocytopenia in advanced gastric cancerKyoko Yamaguchi, Hitoshi Kusaba, Akitaka Makiyama, et al.
Cancer Science|August 2, 2018
Activation of central/effector memory T cells and T-helper 1 polarization in malignant melanoma patients treated with anti-programmed death-1 antibodyKyoko Yamaguchi, Koji Mishima, Hirofumi Ohmura, et al.
Case Reports in Oncology|September 10, 2014
Successful chemoradiotherapy for undifferentiated malignant neoplasm arising from the left pulmonary arteryHozumi Kumagai, Kenta Nio, Yuta Okumura, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|April 12, 2025
Elucidation of the mechanism of carcinogenic transformation of human gastric epithelial cells in atrophic gastritisTomoyasu Yoshihiro, Kyoko Yamaguchi, Hiroshi Ariyama, et al.
Pageof 19